XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- Palliative & Supportive Care
- Basic Science
- COVID-19
- Leukemia
- Lymphoma
- Myeloma
- MDS and MPN
- Benign Hematology
- Lung
- Business
- Event
Playback speed
10 seconds
Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassemia and Sickle Cell Disease Compared to MUD and Haploidentical HSCT?
43 views
January 18, 2021
Comments 0
Login to view comments.
Click here to Login
Benign Hematology